FTT Logo
Editorial standard: How we test and compare

FDA taps Dexcom as first participant in digital health devices pilot program

Marty S.

·

·

🔬 Health & Fitness Research

Dexcom just became the first company in the FDA’s new digital-health device pilot, putting Dexcom G7 and Abbott Stelo glucose data to work on prediabetes and Type 2, not just diabetes treatment. If it pans out, prevention-focused CGM could be the next thing insurers actually pay for.

Marty’s Take:

The real story isn’t Dexcom G7, it’s the CMS ACCESS Model turning glucose data into a billing code. Once insurers pay for continuous glucose monitoring as prevention, expect Apple Watch Ultra 3 and Garmin Fenix 8 Pro to chase FDA clearance for metabolic features next, not just heart rate. Compare what’s actually clinical-grade today in our best fitness tracker guide before assuming your wearable qualifies.

Source: MobiHealthNews

📖 Our deep dive: Best Fitness Tracker

More from Pulse

FDA Clears Samsung Galaxy Buds 3 Pro and 4 Pro as Over-the-Counter Hearing Aids
Aug 12
Apple Exploring Major Apple Watch Reinvention, Including Screenless Fitness Tracker
Aug 12
Google Pixel Watch 5 Launching Today: New Hardware, Potential Price Increase
Aug 12
Marty S.

Marty S.

Marty is a contributor at Fitness Tech Trends, focused on helping readers cut through the noise and make informed decisions about fitness technology. He dives deep into product comparisons, analyzes features that actually matter, and breaks down technical specs into practical insights. Whether readers are choosing between heart rate monitors, deciding on recovery tools, or figuring out which smartwatch fits their training style, Marty aims to provide straightforward, no-hype guidance. When he’s not researching the latest gear, he’s probably testing theories about what makes certain products stick while others fade into the gadget graveyard.